3H-Cyclopent[ij]indolo[2,3-a]quinolizine-13a(13bH)-aceticacid, 5,6,6a,11,12,13-hexahydro-9-methoxy-, methyl ester, (6aR,11aR,13aS,13bS)- (2447-60-1)

Identification
Name:	3H-Cyclopent[ij]indolo[2,3-a]quinolizine-13a(13bH)-aceticacid, 5,6,6a,11,12,13-hexahydro-9-methoxy-, methyl ester, (6aR,11aR,13aS,13bS)-
Synonyms:	Schizophylline(7CI,8CI); Vallesamidin-21-oic acid, 6,7-didehydro-1-demethyl-16-methoxy-,methyl ester, (2b,5a,19a)-
CAS:	2447-60-1
Molecular Formula:	C21H26 N2 O3
Molecular Weight:	0
Molecular Structure:
Properties
Safety Data

Other Product

5H,13bH-13a,13c-Ethano-3H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridin-12(13H)-one,6,6a-dihydro-9-methoxy-, (6aS,13aS,13bS,13cR)- (9CI)
3H-Cyclopent[ij]indolo[2,3-a]quinolizine-12-carboxylicacid, 13a-ethyl-5,6,6a,11,12,13,13a,13b-octahydro-, methyl ester,(6aS,11aS,13aR,13bS)-
1H-Indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylicacid, 13a-ethyl-2,3,5,6,13a,13b-hexahydro-9-methoxy-, methyl ester,(13aS,13bS)-
5H,13bH-13a,13c-Ethano-3H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridin-12(13H)-one,6,6a-dihydro-8,9-dimethoxy-, (6aS,13aS,13bS,13cR)- (9CI)
3H-Cyclopent[ij]indolo[2,3-a]quinolizine-12- methanol,13a-ethyl-5,6,6a,11,12,13,13a,13boctahydro-,(6aS,11aS,13aR,13bS)-
1H-Indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylicacid, 13a-ethyl-2,3,5,6,12,13,13a,13b-octahydro-12-hydroxy-9-methoxy-, methylester, (12S,13aS,13bS)-
1H-Indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylicacid, 13a-ethyl-2,3,5,6,13a,13b-hexahydro-, (13aS,13bS)-
1H-Indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-methanol,13a-ethyl-2,3,5,6,13a,13b-hexahydro-, (13aS,13bS)-
methyl (13aS,13bS)-13a-ethyl-2,3,5,6,13a,13b-hexahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate 4-oxide
1H-Indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylicacid, 13a-ethyl-2,3,5,6,12,13,13a,13b-octahydro-12-hydroxy-, methyl ester,hydrochloride (1:1), (12S,13aS,13bS)-
(12S,13aS,13bS)-13a-Ethyl-2,3,5,6,12,13,13a,13b-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylic acid methyl ester
11H-6a,12-(Epoxymethano)-11a,13a-ethano-3H-pyrrolo[1',2':1,8]azocino[5,4-b]indole-11-carboxylicacid, 5,6,14,15-tetrahydro-8-methoxy-3,16-dioxo-, methyl ester, (6aR,11aR,12R,13aR)-rel-(+)-(9CI)
11,13b-Methano-13bH-cyclopent[1,8]azuleno[5,- 4-c]azonine-2-carboxylic acid,13-(acetyloxy)-13a-[(acetyloxy)methyl]- 1,2,2a,3,4,5,6,6a,7,8,9,10,11,12,13,13ahexadecahydro- 14-hydroxy-10-methyl-,methyl ester,(2R,2aR,6aS,10R,11R,13R,13aS,- 13bR,14S)-
methyl (12S,13aS,13bS)-13a-ethyl-12-hydroxy-2,3,5,6,12,13,13a,13b-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate 4-oxide
11H-6a,12-(Epoxymethano)-11a,13a-ethano-3H-pyrrolo[1',2':1,8]azocino[5,4-b]indole-11-carboxylicacid, 5,6,12,13-tetrahydro-16-oxo-, methyl ester, (6aR,11aR,12R,13aR)- (9CI)
(41S,13aS)-13a-ethyl-2-hydroxy-2,3,5,6,13,13a-hexahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridin-12(41H)-one
(3aS,5S,9S,9aS,10S,13aS,13bS)-2,2-di-tert-butyl-5-((tert-butyldimethylsilyl)oxy)-9,10-dihydroxy-6,15,15-trimethyl-4,5,8,9,11,12-hexahydro-13bH-3a,7:9a,13a-dimethanobenzo[3,4]cyclodeca[1,2-d][1,3,2]dioxasilol-13(10H)-one
(41’S,13a’R)-13a’-ethyl-3’,41’,5’,6’,13’,13a’-hexahydrospiro[[1,3]dithiane-2,2’-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridin]-12’(1’H)-one
1,3-Dioxolo[6,7]indeno[2,1-a][3]benzazepin-8-ol,6,6a,11,12,13,13a-hexahydro-6a,9-dimethoxy- 13-methyl-,(6aR,13aS)-
1H-Indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylicacid, 2,3,5,6,13a,13b-hexahydro-13a-(2,2,2-trifluoroethyl)-, ethyl ester,(13aR,13bS)-rel-